Cryoneurolysis for Spasticity Treatment: Long-term Clinical Outcomes and Mechanisms in the Central Nervous System
NCT06958289 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25
Last updated 2026-04-21
Summary
Spasticity can make regular daily activities difficult or impossible. Cryoneurolysis is a new technique to treat spasticity that is currently being tested. For this technique, a needle is inserted alongside a nerve implicated in spasticity. The needle then freezes and causes the nerve to break down. The nerve breaking down seems to provide relief for spasticity. The investigators are interested in testing the long-term effects of cryoneurolysis on the function of the brain over six months after treatment. The investigators are testing the brain's function using transcranial magnetic stimulation (TMS) which involves a magnet activating specific parts of the brain that cause muscles to fire; magnetic resonance imaging (MRI) which uses to examine brain structure; functional near-infrared spectroscopy (fNIRS) to examine brain function. The investigators believe that there will be a change in these measures that are related to the long-lasting effects of cryoneurolysis. Cryoneurolysis is not a part of standard care after stroke but is approved in Canada for patients. It has been used extensively in the past for treating pain. TMS is a way of studying how the brain sends signals to muscles to make movement. During these sessions, a researcher will use a magnet to turn on specific neurons in the brain that will cause muscles to contract. The investigators can study the way eyes and muscles respond to better understand how the brain is sending information about moving the body to the muscles. FNIRS is a new way of studying how the brain works. During these sessions, a researcher will fit the participant with a cap that has several lights on it. The light travels through hair, scalp, and skull where it interacts with blood in the brain. By studying the changes in the colour of the blood in the brain, researchers can understand which parts of the brain are active during specific tasks. Magnetic Resonance Imaging (MRI) involves a powerful magnet that takes very detailed pictures of the brain. These images help the investigators to understand how a stroke is related to spasticity. Also, these images are helpful to make the stimulation with TMS more accurate. Study participation will require five visits to the Parkwood Institute Main Building and one visit to St. Joseph's Hospital. The entire study will take place over roughly six months. The investigators are recruiting 25 people with stroke who are eligible for cryoneurolysis to participate in the study.
Conditions
- Spasticity as Sequela of Stroke
Interventions
- DEVICE
-
Cryoneurolysis
Each participant will receive cryoneurolysis which involves the application of extreme cold directly to, or near targeted nerves under ultrasound guidance. This cold causes axonotmesis to occur, thereby completely preventing the treated nerve from propagating any signal. Cryoneurolysis produces an effect called Wallerian degeneration, where the treated nerve's axon is destroyed but the epineurium and perineurium are left intact. Therefore, the axon can regenerate, following the same path as prior to treatment.
Sponsors & Collaborators
-
Pacira Pharmaceuticals, Inc
collaborator INDUSTRY -
Sue Peters
lead OTHER
Principal Investigators
-
Sue Peters, PhD · Western University
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-08-01
- Primary Completion
- 2027-12-01
- Completion
- 2028-05-01
- FDA Device
- Yes
Countries
- Canada
Study Locations
More Related Trials
-
Early Botulinum Toxin for Muscle Stiffness Reduction in First-Time Stroke Patients: Improving Recovery and Independence
NCT06811142 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
The Effect of Extracorporeal Shock Wave Therapy After Botulinum Toxin Type A Injection for Post-stroke Spasticity
NCT05889026 ·Status: COMPLETED ·Phase: NA
-
Study of Intramuscular Injections of OnabotulinumtoxinA to Assess Change in Disease Activity in Pediatric Participants With Spasticity Associated With Cerebral Palsy
NCT06150729 ·Status: COMPLETED
-
Injecting Botulinum Toxin A Underneath the Skin to Treat Spinal Cord Pain in Patients With Spinal Cord Injury
NCT02736890 ·Status: TERMINATED ·Phase: PHASE2
-
Botulinum Toxin (BOTOX) for Cerebral Palsy
NCT00060957 ·Status: COMPLETED ·Phase: PHASE2
-
OnabotulinumtoxinA Treatment in Adult Patients With Upper Limb Spasticity
NCT02145676 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy and Safety of SPARC0921 in Subjects With Spasticity
NCT01457352 ·Status: COMPLETED ·Phase: PHASE3
-
Exploring Advanced Imaging Techniques to Characterize Botulinum Toxin Diffusion in Human Muscle
NCT01412008 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of an Interprofessional Approach to the Treatment of Spasticity With Botulinum Toxin & Non-pharmacological Therapies
NCT07160699 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Neurotoxin and Physical Therapy
NCT02177617 ·Status: COMPLETED ·Phase: PHASE4
-
Botox vs. Baclofen for Upper Limb Spasticity
NCT00280280 ·Status: TERMINATED ·Phase: PHASE1
-
Long-Term Study of OnabotulinumtoxinA Treatment in Adult Patients With Upper Limb Spasticity
NCT02145689 ·Status: WITHDRAWN ·Phase: PHASE3
-
The Effect of Ultrasound-Guided Botulinum Toxin Injections on Pain, Functionality, Spasticity, and Range of Motion in Patients With Post-Stroke Upper Extremity Spasticity
NCT05887479 ·Status: WITHDRAWN ·Phase: PHASE4
-
Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke
NCT01392300 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Dose Titration Study of Botulinum Toxin Type A to Treat Spasticity in the Leg and Arm
NCT01603459 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Shock Wave Therapy in Post-Stroke Muscle Spasticity Management
NCT06815328 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Botox Injections in Non-Cranial Nerve VII Innervated Muscles for Facial Synkinesis
NCT07295288 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Best Management of Muscle Relaxation- Objective Monitoring
NCT03958201 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Responsiveness of Seven Functional Tasks in Patients With Poststroke Upper Limb Spasticity With Botulinum Toxin Type A Treatment
NCT00651690 ·Status: COMPLETED ·Phase: PHASE2
-
Investigating Botulinum Toxin A to Treat Acute Neck/Upper Shoulder Pain Following a New Spinal Cord Injury.
NCT00320281 ·Status: COMPLETED ·Phase: PHASE4
-
Dry Needling and Botulinum Toxin in the Management of Poststroke Spasticity
NCT03747900 ·Status: COMPLETED ·Phase: NA
-
Neubotulinum Toxin Injection in Cerivical Dystonia
NCT04582929 ·Status: COMPLETED ·Phase: PHASE3
-
Dose-escalating Safety and Preliminary Efficacy of DaxibotulinumtoxinA for Injection in Cervical Dystonia
NCT02706795 ·Status: COMPLETED ·Phase: PHASE2
-
Muscle Elastography in Spastic Cerebral Palsy
NCT03112434 ·Status: COMPLETED
-
The Movement of Botulinum Toxin Through the Lateral Gastrocnemius Muscle in Humans: An Expanded Examination
NCT03367429 ·Status: TERMINATED ·Phase: PHASE4